{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:30:19Z","timestamp":1789421419964,"version":"build-2803163510"},"reference-count":16,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.4065\/83.4.457","type":"journal-article","created":{"date-parts":[[2009,1,22]],"date-time":"2009-01-22T21:33:26Z","timestamp":1232660006000},"page":"457-459","source":"Crossref","is-referenced-by-count":45,"title":["JAK2V617F Mutation Screening as Part of the Hypercoagulable Work-up in the Absence of Splanchnic Venous Thrombosis or Overt Myeloproliferative Neoplasm: Assessment of Value in a Series of 664 Consecutive Patients"],"prefix":"10.4065","volume":"83","author":[{"given":"Animesh","family":"Pardanani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terra L.","family":"Lasho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kebede","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Schwager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristy M.","family":"Finke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv K.","family":"Pruthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayalew","family":"Tefferi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.4065\/83.4.457_bib1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2141.2004.05277.x","article-title":"Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia","volume":"128","author":"Elliott","year":"2005","journal-title":"Br J Haematol"},{"issue":"1","key":"10.4065\/83.4.457_bib2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/sj.leu.2404955","article-title":"Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms","volume":"22","author":"Tefferi","year":"2008","journal-title":"Leukemia"},{"issue":"7","key":"10.4065\/83.4.457_bib3","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1053\/j.gastro.2006.04.008","article-title":"Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome","volume":"130","author":"Patel","year":"2006","journal-title":"Gastroenterology"},{"issue":"6","key":"10.4065\/83.4.457_bib4","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/hep.21435","article-title":"Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis","volume":"44","author":"Primignani","year":"2006","journal-title":"Hepatology"},{"issue":"6","key":"10.4065\/83.4.457_bib5","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/jmg.2006.048371","article-title":"Gain-of-function gene mutations and venous thromboembolism: distinct roles in different clinical settings","volume":"44","author":"Colaizzo","year":"2007","journal-title":"J Med Genet"},{"issue":"4","key":"10.4065\/83.4.457_bib6","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1538-7836.2007.02384.x","article-title":"JAK2 V617F is specifically associated with idiopathic splanchnic vein thrombosis [letter]","volume":"5","author":"Regina","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"9","key":"10.4065\/83.4.457_bib7","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1182\/blood-2006-05-021527","article-title":"Latent myeloproliferative disorder revealed by the JAK2-V617F mutation and endogenous megakaryocytic colonies in patients with splanchnic vein thrombosis [letter]","volume":"108","author":"Boissinot","year":"2006","journal-title":"Blood"},{"issue":"8","key":"10.4065\/83.4.457_bib8","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1038\/sj.leu.2404710","article-title":"JAK2V617F prevalence and allele burden in non-splanchnic venous thrombosis in the absence of overt myeloproliferative disorder [letter]","volume":"21","author":"Pardanani","year":"2007","journal-title":"Leukemia"},{"issue":"8","key":"10.4065\/83.4.457_bib9","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1111\/j.1538-7836.2007.02616.x","article-title":"JAK2V617F is infrequently associated with arterial stroke in the absence of overt myeloproliferative disorder [letter]","volume":"5","author":"Pardanani","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"6","key":"10.4065\/83.4.457_bib10","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1365-2141.2007.06715.x","article-title":"JAK2V617F in idiopathic venous thromboembolism occurring in the absence of inherited or acquired thrombophilia [letter]","volume":"138","author":"Rossi","year":"2007","journal-title":"Br J Haematol"},{"issue":"2","key":"10.4065\/83.4.457_bib11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3324\/haematol.10358","article-title":"The V617F mutation of JAK2 is very uncommon in patients with thrombosis [letter]","volume":"92","author":"Remacha","year":"2007","journal-title":"Haematologica"},{"issue":"6","key":"10.4065\/83.4.457_bib12","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1600-0609.2007.00960.x","article-title":"The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis\u2014impact on disease phenotype","volume":"79","author":"Larsen","year":"2007","journal-title":"Eur J Haematol"},{"issue":"11","key":"10.4065\/83.4.457_bib13","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1002\/cncr.22663","article-title":"Clinical correlates of JAK2V617F allele burden in essential thrombocythemia","volume":"109","author":"Kittur","year":"2007","journal-title":"Cancer"},{"issue":"10","key":"10.4065\/83.4.457_bib14","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1038\/sj.leu.2404755","article-title":"The quantitative JAK2 V617F neutrophil allele burden does not correlate with thrombotic risk in essential thrombocytosis [letter]","volume":"21","author":"Pemmaraju","year":"2007","journal-title":"Leukemia"},{"issue":"5","key":"10.4065\/83.4.457_bib15","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/sj.leu.2404588","article-title":"Comparison of whole blood vs purified blood granulocytes for the detection and quantitation of JAK2(V617F) [letter]","volume":"21","author":"Hermouet","year":"2007","journal-title":"Leukemia"},{"issue":"1","key":"10.4065\/83.4.457_bib16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/sj.leu.2404948","article-title":"JAK2 inhibitor therapy in myeloproliferative disorders: rationale, preclinical studies and ongoing clinical trials","volume":"22","author":"Pardanani","year":"2008","journal-title":"Leukemia"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611607015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611607015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T09:17:48Z","timestamp":1558084668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611607015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0025619611607015"],"URL":"https:\/\/doi.org\/10.4065\/83.4.457","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}